The Evolution Of US FDA Advisory Committee Votes On COVID-19 Vaccines

From surprisingly contentious to surprisingly unanimous, VRBPAC's favorable votes have grown from 17 to 21 over the course of three meetings on coronavirus vaccines.

Closeup of multiethnic men and women raising hands against white background. Shutterstock-144918361 — The VRBPAC voted 21-0 to recommend an emergency use authorization for the J&J COVID-19 vaccine.

Dissent among the US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee faded as it reviewed more coronavirus vaccine candidates.

After a confusing 17-4 vote with one abstention supporting a recommendation that the benefits of the Pfizer Inc./BioNTech...